Our Score

7.7/10

From$179/mofirst month, then $299/mo

TypeBoth

InsuranceNo

Rank#18 of 53

Brand-nameCompoundedUpdated May 17, 2026

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated May 17, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

Researched against FDA labeling, published clinical-trial data (STEP-1 / SURMOUNT-1), and MEDVi's live pages, not a paid placement.

MEDVi Review (2026): Compounded GLP-1 with Oral + Injectable

Name: MEDVi GLP-1 Program
Brand: MEDVi
Price: 179 USD
Availability: InStock
Rating: 4.4 (11000 reviews)

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake, one of the broader compounded mixes among independent telehealth providers in 2026.

Bottom line

MEDVi is the best option for needle-averse users who want a clear pathway from oral to injectable GLP-1 treatment. Full verdict ↓

Independently researched. Every statistic links to a primary source (NEJM, JAMA, FDA, CMS, or the provider's official disclosures). Affiliate status never changes a provider's score; featured picks are affiliate partners, disclosed. Last verified May 17, 2026.

Visit MEDVi

Clinical evidence: 20.9% average body-weight reduction at 72 weeks in SURMOUNT-1 (NEJM, 2022). Individual results vary; compounded GLP-1s are not FDA-approved.

Summarize this article with

ChatGPT Perplexity Gemini Claude

MEDVi scores 7.7/10 in our independent review, starting at $179/mo for brand-name and compounded GLP-1 medications. MEDVi is one of the few platforms offering both oral tablets and injectable compounded semaglutide, backed by a 4.4/5 Trustpilot rating across roughly 11,000 reviews.

What makes it different: The only compounded GLP-1 platform offering a structured oral-to-injectable transition pathway with micro-dosing options for side-effect-sensitive patients.

At a glance

Get MEDVi if

Needle-averse users who want to start with oral and potentially transition to injectable
Patients with GI sensitivity who want micro-dosing below standard protocols
Users who value a sleek digital experience with progress tracking

Skip if

Users who want brand-name FDA-approved Wegovy or Zepbound (MEDVi added Ozempic in 2026 but not Wegovy/Zepbound)
Those who need insurance billing
Patients who want a long, established track record (MEDVi launched 2023)

Sounds like you? Visit MEDVi

MEDVi Pros and Cons

What We Like

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179/mo is competitive for a platform with both oral and injectable compounded formulations

What Could Be Better

−No brand-name Wegovy or Zepbound on the platform (the 2026 expansion added branded Ozempic only)
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms; you can switch to injectable anytime at no extra fee if results lag

What it costs

Headline pricing, full-year math, and how MEDVi compares to the closest alternatives.

Quick facts

Monthly Cost

From $179/mo

Consultation

Included

Availability

All 50 States

Insurance

Not Accepted

Shipping

Free

Cancellation

Cancel anytime with 7-day no...

All pricing tiers

Injectable Semaglutide (first month)

$179/mo

Introductory first-month rate for injectable compounded semaglutide

Injectable Semaglutide (ongoing)

$299/mo

Ongoing monthly rate for injectable compounded semaglutide

Oral Semaglutide Tablets (first month)

$249/mo

Introductory first-month rate for oral compounded semaglutide

Oral Semaglutide Tablets (ongoing)

$369/mo

Ongoing monthly rate for oral compounded semaglutide

Compounded Tirzepatide (first month)

$279/mo

Introductory first-month rate for compounded tirzepatide (injectable or oral)

Compounded Tirzepatide (ongoing)

$399/mo

Ongoing monthly rate for compounded tirzepatide

Brand-name Ozempic

$1999/mo

FDA-approved Ozempic cash price, added in 2026

Cancellation policy: Cancel anytime with 7-day notice

What customers say

What third-party review aggregators say about MEDVi. Cards show the verified primary metric only, “Not found” means no public profile surfaced in our verification pass.

Trustpilot

4.4★

11000 verified reviews

How we verified this →

BBB

F (not accredited)

How we verified this →

Mixed sentiment

Aggregated from public threads

Provider claim

None disclosed

Our reading

MEDVi (GLP-1 telehealth, real Trustpilot profile at medvi.org) carries a high 4.4/5 TrustScore across ~11,000+ reviews, with praise for fast approval and responsive support, but its BBB profile is an unaccredited F, and recurring complaints across platforms center on billing confusion and slow refunds (ConsumerAffairs sits lower at ~3.6/5).

What people actually say

Reddit: No substantial dedicated MEDVi Reddit threads surfaced; aggregated third-party sentiment praises fast approval and responsive support but flags recurring billing and refund-delay complaints.

Trustpilot: Verified June 19, 2026, external-reviews verification pass.

How MEDVi works

Health Assessment + Preference Selection

Complete your health profile and indicate your preference for oral tablets or injectable semaglutide. MEDVi's intake specifically addresses needle concerns and GI sensitivity.

Provider Consultation + Micro-Dose Option

Your provider reviews your profile and can start you at micro-doses below standard protocols if you're concerned about side effects. Oral or injectable, your choice.

Treatment + Progress Tracking

Medication ships free. Track your weight, side effects, and milestones through MEDVi's patient portal. Transition from oral to injectable anytime.

Medications available

Semaglutide (compounded injectable)Semaglutide (compounded oral tablets)Tirzepatide (compounded injectable, added 2026)Tirzepatide (compounded oral tablets, added 2026)Ozempic (brand-name, added 2026)

Ready to check MEDVi's pricing for yourself?

Visit MEDVi

Is MEDVi legit?

Six trust signals, how we checked them, and what's been updated since the last review.

Is MEDVi legit? Read the full verification for the Trustpilot record, the named pharmacy, and the specific complaints we could and could not substantiate.

Independent Clinical Perspective

What the doctors say about GLP-1 medications

Independent, sourced clinical context on the medication class, not a comment on this provider.

“Our research highlights the safety and the potential for GLP-1 receptor agonists to reduce the risk of acute pancreatitis recurrence in individuals with obesity and type 2 diabetes, challenging previous concerns and offering new hope for effective disease management.”

Mahmoud Nassar, MD, PhD, Endocrinology, Diabetes & Metabolism

University at Buffalo, Jacobs School of Medicine

Research presented at ENDO 2024 re-evaluating pancreatitis risk.

Endocrine Society (ENDO 2024) ↗ · Jun 2024

“More options for people with these challenging diseases will be very helpful, particularly if the new oral tablet medicines are priced reasonably.”

Daniel Drucker, MD, endocrinologist, co-discoverer of GLP-1's biological actions; 2025 Breakthrough Prize laureate

University of Toronto / Sinai Health

On head-to-head data for the oral GLP-1 pill orforglipron vs oral semaglutide.

Scientific American ↗ · Feb 2026

Quotes are general medical commentary about GLP-1 medications, independently sourced and not solicited by GLP-1 Picks. They are not an endorsement of any provider, our provider scores are set solely by our published methodology.

Common questions

Questions readers ask about MEDVi, similar providers to compare, and quick tools.

Frequently Asked Questions

How effective is oral compounded semaglutide vs. injectable?+

Injectable semaglutide generally has higher bioavailability than oral forms. Clinical data shows injectable produces slightly more weight loss on average. However, oral is a reasonable starting point for needle-averse patients, and MEDVi makes it easy to transition to injectable later.

What is micro-dosing and how does it work?+

Micro-dosing starts you at a lower dose than standard protocols (e.g., 0.125mg instead of 0.25mg for injectable). This can reduce initial GI side effects like nausea. Your provider gradually increases the dose based on your tolerance.

Can I switch from oral to injectable mid-treatment?+

Yes, and this is one of MEDVi's key features. Request the switch through your portal, and your provider adjusts your prescription. The price stays the same, no additional fees for the transition.

Does MEDVi offer tirzepatide?+

Yes, as of the 2026 expansion. MEDVi now offers both compounded tirzepatide (injectable and oral tablet, $279 first month / $399 ongoing) and compounded semaglutide. The 2026 lineup added tirzepatide alongside the existing semaglutide formats and brand-name Ozempic.

Is MEDVi's $179 price a first-month offer that goes up later?+

Yes. $179 is the introductory rate and it renews at $299 a month, an increase of 67%. Budget against $299 rather than the advertised number: over a year that is $3,468 rather than $2,148.

What do verified reviews say about MEDVi?+

MEDVi holds Trustpilot: 4.4 across 11,000 reviews; BBB: F (not accredited). We re-check these against the platforms directly rather than taking a provider's own marketing figure, and where the platforms disagree we show all of them. Our own score for MEDVi is 7.7/10, set by a published methodology that a provider cannot pay to change.

Can I cancel MEDVi, and what are the terms?+

MEDVi states: Cancel anytime with 7-day notice. Cancel before your next billing date rather than on it, and keep written confirmation.

Does MEDVi take insurance?+

No. MEDVi is cash pay only, so nothing is billed to a plan. On the listed price: consultation included, shipping free.